CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly licensed Geenius test is an immunochromatographic assay designed to confirm and differentiate individual antibodies to Human Immunodeficiency Virus Types 1 and 2. The assay will be replacing the HIV-1 Western blot and HIV-2 EIA assays which are performed on samples with a reactive result on a licensed HIV 1/2 screening test.
Read all about it on the Communication page by clicking this link: Communications
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
The new online Learning Center with new content can still be found under the “Training” folder on ...
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...